Community Practice

Latest News


CME Content


The National Association of Chain Drug Stores has endorsed a congressional proposal to establish a workgroup to collaborate on solutions to reduce prescription drug abuse and without comprising access to medications.

Health Mart launched its 2014 Healthy Living Tour during the Independent Pharmacy Business Growth Conference in Orlando, Fla. Pharmacists and other healthcare professionals will visit more than 130 communities across the United States providing health education and free health screenings.

Actavis plans to purchase Forest Laboratories for approximately $25 billion in a cash and equity deal, creating a combination of “two of the world’s fastest growing specialty pharmaceutical companies, with combined annual revenues of more than $15 billion in 2015,” according to a Feb. 18 announcement.

FDA approved droxidopa (Northera, Chelsea Therapeutics) capsules for the treatment of neurogenic orthostatic hypotension (NOH). NOH is a rare, chronic and often debilitating condition that is associated with Parkinson's disease, multiple-system atrophy, and pure autonomic failure.

A Christian pharmacist in Tennessee has filed a federal lawsuit against Walgreens claiming the chain fired him for refusing to sell the Plan B morning after pill.

The National Institutes of Health, FDA, 10 biopharmaceutical companies, the Pharmaceutical Research and Manufacturers of America, and several nonprofit organizations have launched an unprecedented public/private partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.

Millions of avoidable cancers could be prevented through widespread human papillomavirus vaccination (HPV), according to a report released by the President's Cancer Panel. And chief amongst the report’s recommendations to prevent these avoidable cancers and deaths is empowering pharmacists to administer HPV vaccinations.

Analysts expect to see key developments in categories that include cancer, heart failure, obesity and diabetes, and hepatitis C. They also look toward some greatly needed antibiotics to deploy in the war against superbugs.

Your district manager is bashing you with metrics at the expense of your patients and pharmacy practice. You're in professional hell. It may be time to activate plan B.